SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI
Sunshine Guojian Pharmaceutical Shanghai is a major antibody drug production base among domestic biopharmaceutical companies. It takes therapeutic antibody drugs as the research and development direction and provides, safe, and effective clinical solutions for the treatment of major diseases such as autoimmune diseases.
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI
Industry:
Biotechnology Health Care Life Science Medical Pharmaceutical
Founded:
2002-01-25
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.3s-guojian.com
Total Employee:
1001+
Status:
Active
Contact:
+86 -21-8029 7777
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Pound Sterling Apple Mobile Web App Capable ASP.NET IIS Japanese Yen Apple Mobile Web App Status Bar Style
Similar Organizations
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
VC Cell Therapy
VC Cell Therapy is a pharmaceutical company that provides regenerative medicines.
Stock Details
Official Site Inspections
http://www.3s-guojian.com Semrush global rank: 7.01 M Semrush visits lastest month: 932
Unable to get host informations!!!
More informations about "Sunshine Guojian Pharmaceutical Shanghai"
About Us - 3s-guojian.com
Founded in 2002, Sunshine Guojian is one of the first batch of Chinese innovative biopharmaceutical enterprises focusing on antibody drugs and is also a domestic pharmaceutical enterprise with three listed therapeutic antibody drugs in …See details»
公司概况|关于我们|三生国健药业（上海）股份有限公司
三生国健药业（上海）股份有限公司See details»
Sunshine Guojian Pharmaceutical Shanghai - Crunchbase
Also Known As Citic Guojian; Legal Name Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. Stock Symbol SSE:688336 ; Company Type For Profit; …See details»
三生国健 - 3s-guojian.com
三生国健举报途径. 如您发现或者怀疑三生国健员工在商业活动中存在任何合规问题，请通过以下途径举报. 邮箱：[email protected] 电话：400-021-2291 电话：400-021-2291See details»
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
了解Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (三生国健药业（上海）股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的105项临床试验, 1篇新闻和5篇文献，疾病 …See details»
三生国健药业(上海)股份有限公司 公司概况 - 中国 | 财务及主要执 …
Nov 24, 2024 三生国健药业(上海)股份有限公司是中国中的企业， 与主办公室在上海。 它在医药制造行业运营。 该公司成立于2002.01.25。See details»
3SBIO
1st 3, 10th Road, Economic and Technological Development Zone, Shenyang, China. Phone: +86 024 2538 6000. Fax: +86 024 2581 1821. E-mail: [email protected]See details»
Innovative biopharmaceutical company focusing on …
Sunshine Guojian is an innovative biopharmaceutical company focusing on antibody drugs, as well as a high-tech enterprise with independent research and development, industrialization and commercialization capabilities. The …See details»
Sunshine Guojian Pharmaceutical Co., Ltd - CMOCRO
Sunshine Guojian is a biopharmaceutical company invested and controlled by China International Trust and Investment Corporation (CITIC Limited). CPGJ has committed to the R and D, pilot …See details»
Numab Therapeutics and 3SBio’s Subsidiary Sunshine Guojian …
Please visit www.3s-guojian.com for additional information. Contacts: For Numab Therapeutics David Urech Chief Executive Officer [email protected] For media MacDougall Sara …See details»
三生国健自主研发重组抗IL-1β人源化单克隆抗体注射液（SSGJ-613…
中国抗体药物先行者三生国健（证券代码：688336）宣布，公司近日收到国家药品监督管理局（以下简称“国家药监局”）核准签发的《药物临床试验批准通知书》，批准旗下产品——重组抗il …See details»
三生国健重组抗EGFR人鼠嵌合单克隆抗体（CPGJ602）注射液II期 …
三生国健重组抗egfr人鼠嵌合单克隆抗体（cpgj602）注射液ii期临床试验完成所有受试者入组 2021-10-18See details»
联系我们|关于我们|三生国健药业（上海）股份有限公司
三生国健药业（上海）股份有限公司 地址：中国（上海）自由贸易试验区李冰路399号 邮编：201203. 电话：+86 021-8029 7777See details»
三生国健公布2022年年度报告 - 美通社
Mar 22, 2023 目前，公司拥有13个处于不同开发阶段的在研创新药物，其中大部分在研药物为治疗用生物制品1类，部分在研药物为中美双报。请访问www.3s-guojian.com获取更多信息。 警 …See details»
三生国健药业（上海）股份有限公司 - 爱企查
23 hours ago 爱企查为您提供三生国健药业（上海）股份有限公司的企业信息查询服务，查询三生国健药业（上海）股份有限公司工商注册信息、电话邮箱、公司地址、经营风险、控股持股 …See details»
新闻中心 - 3s-guojian.com
Mar 20, 2024 [email protected] 上一条：三生国健公布2024年一季报：销售收入稳步增长，自免临床高效推进 下一条：三生国健重组抗IL-4Rα人源化单克隆抗体注射液（611） …See details»
三生国健药业（上海）股份有限公司 关于召开 2023 年第三季度业 …
箱[email protected]进行提问。公司将在说明会上对投资者普遍关 注的问题进行回答。 三生国健药业（上海）股份有限公司（以下简称“公司”）已于 2023年10月19日发布公司2023年第三季 …See details»
新药研发|我们的技术|三生国健药业（上海）股份有限公司
新药研发 三生国健已上市产品3个，在研产品14个。公司拥有专业化的抗体药物研发平台，并为“抗体药物国家工程研究中心” 提供技术和智力资源支持。See details»